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Abstract
Objective—Pediatric bipolar disorder involves poor social functioning, but the neural
mechanisms underlying these deficits are not well understood. Previous neuroimaging studies
have found deficits in emotional face processing localized to emotional brain regions. However,
few studies have examined dysfunction in other regions of the face processing circuit. This study
assessed hypoactivation in key face processing regions of the brain in pediatric bipolar disorder.
Method—Youth with a bipolar spectrum diagnosis (n=20) were matched to a nonbipolar clinical
group (n=20), with similar demographics and comorbid diagnoses, and a healthy control group
(n=20). Youth participated in a functional magnetic resonance imaging (fMRI) scanning which
employed a task-irrelevant emotion processing design in which processing of facial emotions was
not germane to task performance.
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Results—Hypoactivation, isolated to the fusiform gyrus, was found when viewing animated,
emerging facial expressions of happiness, sadness, fearfulness, and especially anger in pediatric
bipolar participants relative to matched clinical and healthy control groups.
Conclusions—The results of the study imply that differences exist in visual regions of the
brain’s face processing system and are not solely isolated to emotional brain regions, such as the
amygdala. Findings are discussed in relation to facial emotion recognition and fusiform gyrus
deficits previously reported in the autism literature. Behavioral interventions targeting attention to
facial stimuli might be explored as possible treatments for bipolar disorder in youth.
Keywords
emotion; face processing; functional magnetic resonance imaging (fMRI); fusiform; gyrus;
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Introduction
Pediatric bipolar spectrum disorders (BPSD), including bipolar I and II disorders,
cyclothymic disorders, and bipolar disorder not otherwise specified (NOS), are debilitating
illnesses affecting approximately 2% of the child and adolescent population1. In addition to
the well documented clinical impairments found in children suffering from BPSD2, Geller et
al.3 reported significant psychosocial deficits. They found that the majority of children with
BPSD had few friends, poor social skills, and hostile relationships with parents and siblings.
While it is difficult to disentangle whether these psychosocial deficits are a cause or an
effect of the disorder, research into basic social processes, and the accompanying neural
deficits related to these processes, can help inform therapeutic treatments for children with
BPSD.
Several studies of pediatric BPSD4–10 have focused on emotional face processing due to its
associations with social impairment11. Youth with BPSD have lower accuracy in identifying
emotional facial expressions compared to their healthy counterparts or children with other
forms of psychopathology(e.g. ADHD, ODD, anxiety)8. They also have impairments in
memory of faces12 and are more likely to misinterpret neutral faces as threatening5. Further,
this effect has been found in those youth at familial risk of BPSD13. Functional Magnetic
Resonance Imaging(fMRI) studies have also examined impairment in emotional face
processing, mostly focusing on dysfunction in the amygdala, an important emotional brain
region in the face processing circuit5,6. Rich et al. found amygdala hyperactivation,
compared to control participants, when rating perceived fear of an emotional face5 and
reduced functional connectivity to other regions in the face processing circuit6.
Although there is a wealth of literature indicating amygdala dysfunction during judgment of
emotional faces, few, if any, studies have focused on other parts of the emotional face
processing system in pediatric BPSD. One critical component of the brain’s face processing
circuit is the “fusiform face area,” a region localized to the lateral fusiform gyri (FG) that is
specialized for face perception14,15. Limited evidence indicates that there may also be
impairment in this area in pediatric BPSD. While neural activity in the FG was not
examined directly, Rich et al. found decreased connectivity between the hyperactivated
amygdala and this region on an emotional face judgment task in children with BPSD
compared to their healthy counterparts6. This may indicate abnormal functioning in the FG
itself or simply inefficient communication within the face processing circuit (e.g.,
hyperactivation of the amygdala as a compensatory attempt to communicate with the FG
through impaired connections). Adleman et al. also found that faces that were remembered
vs. forgotten in youth with BPSD were encoded differently in the FG compared to healthy
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subjects12. Studies of adult patients with BPSD have examined structural changes in this
region with inconclusive results. Adler et al. showed increased gray matter volume in the
FG16 while Moorhead et al. reported a decline in gray matter density, compared to control
participants, over a 4-year period17.
A second brain region of importance in the face processing circuit is the superior temporal
sulcus (STS), which is noted for its role in the perception of biological motion and social
action interpretation18. The STS is particularly sensitive to the eye-gaze19,20, head
movement21, and mouth motion22. Very little research has focused on the STS in children
with BPSD, likely due to the lack of evidence of impaired biological motion processing in
this group. Pavuluri et al.23 did, however, find that pediatric BPSD patients showed elevated
activation in the STS, in comparison to healthy children, while viewing angry faces.
The current study was designed to test the possibility of impairment in the entirety of the
face processing system in youth with BPSD, which could potentially underlie deficits in
emotional face judgment and social interaction3,8. Given the previous literature indicating
poor performance in emotional face judgment tasks, the instructions for the task used in the
current study did not focus on emotion judgment, potentially enhancing our sensitivity to
examine differences outside limbic regions. This allowed us to eliminate the possibility that
findings might be due to higher order differences in cognitive functioning rather than
discrete visual processing of facial stimuli. Further, given evidence for impairments in FG
and STS activity in other forms of psychopathology24–26, we collected data from an
additional group of children who were matched on demographic characteristics and
comorbid psychopathology to the BPSD group(e.g., anxiety, disruptive behavior, attention-
deficit/hyperactivity disorder [ADHD]), but who did not have BPSD, as well as a
nonclinical healthy control group.
Method
All methods for recruitment and participant testing were approved by the institutional
review boards (IRBs) of all participating universities.
Participants
Forty youth (9.89–16.88 years; M=13.61, SD=1.95) who had been recruited into the original
Longitudinal Assessment of Manic Symptoms Study (LAMS1) participated in the second
phase of this project (LAMS2). LAMS1 was a multi-site study in which youth, ages 6–12,
were recruited as they sought care for a variety of diagnoses in nine mental health outpatient
clinics associated with the 4 collaborating universities. The original goal of LAMS1 was to
employ longitudinal clinical assessment to determine early risk for BPSD27,28. For the
current study (LAMS2), beginning 5 years after the start of LAMS1, these youth returned to
participate in neuroimaging procedures and clinical assessments (see below). From this
sample, 20 youth who had obtained a bipolar spectrum diagnosis (BPSD) at or between
entry into LAMS1 and start of LAMS2, and who had artifact-free neuroimaging data, were
matched, to the best of our ability, to 20 clinic youth without a bipolar spectrum diagnosis
(Non-BPSD) on demographic characteristics (age, sex, IQ, socioeconomic status [SES]) and
comorbid diagnoses. The Non-BPSD clinical group was quite heterogeneous in diagnosis
but did not statistically differ from the BPSD group in categories of comorbid diagnosis (see
Table 1). The BPSD group comprised 11 subjects with bipolar I disorder, 6 subjects
diagnosed with bipolar NOS, and 3 subjects with cyclothymic disorder. No subjects in this
sample had been diagnosed with bipolar II disorder. The amount of time between intake into
the LAMS1 study and participation in the LAMS2 scan procedure ranged between 2.47 and
5.97 years (mean=4.42 years, SD=0.83 years). An additional, newly recruited, sample of 20
mentally and physically healthy participants (Control) without personal or family history of
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mood disorders in first degree, and without family history of BPSD in second degree,
relatives were also included in the neuroimaging procedures. These participants were
matched on demographic variables to the BPSD and Non-BPSD participants (see Table 1).
Participants were recruited from 3 of the LAMS sites: Case Western Reserve University
(n=24, 9 BPSD, 6 Non-BPSD, 9 Control); Cincinnati Children’s Hospital (n=15, 7 BPSD, 7
Non-BPSD, 1 Control); and University of Pittsburgh Medical Center/Western Psychiatric
Institute and Clinic (n=21, 4 BPSD, 7 Non-BPSD, 10 Control). Parents/guardians provided
written informed consent, and youth provided written informed assent prior to study
participation. Participants received monetary compensation and a framed picture of their
structural neuroimaging scan29.
Exclusion criteria included severe systemic medical illnesses, neurological disorders, history
of head trauma with loss of consciousness, use of medications that may produce central
nervous system (CNS) effects (e.g., steroids), IQ<70 (assessed by the Wechsler Abbreviated
Scale of Intelligence)30, positive urine drug and/or salivary alcohol screen on the day of the
scan, alcohol or substance abuse in the past 3 months (determined by the Schedule for
Affective Disorders and Schizophrenia for School Age Children, Present and Life Version;
K-SADS-PL-W31), visual disturbance (less than 20/40 Snellen visual acuity), being unable
to complete questionnaires in English, parent-reported history of physical/sexual abuse,
autism spectrum disorders or developmental delays, posttraumatic stress disorder, and taking
more than 3 different psychotropic medications. Additional exclusion criteria for scanning
included pregnancy, claustrophobia, or metal objects in the body. LAMS youth were
permitted to use prescribed medication(s) before scanning, given ethical problems with
stopping medication for research purposes.
Symptom Assessment
Diagnostic assessments of the LAMS participants were performed annually by interviewing
the caregiver and child using the K-SADS-PL-W. In addition, the mood modules of the K-
SADS-PL-W interview were performed semianually27,28. The number of months between
the nearest K-SADS-PL-W assessment and scan date ranged between 3.9 months before the
scan to 4.5 months after the scan. Based on this interview, participants were given a yes/no
score for a lifetime history of each of 5 diagnostic categories (BPSD, depression, anxiety,
ADHD, and disruptive behavior disorders [i.e., conduct disorder or oppositional defiant
disorder]). No participant was given a lifetime history diagnosis of a substance use disorder
(see Table 1). BPSD and Non-BPSD participants were matched on all diagnoses other than
BPSD and on the demographic variables mentioned above.
Paradigm
Participants completed a 13-minute emotional dynamic faces task32 during fMRI scanning.
Participants were asked to use one of three fingers to press a button indicating the color of a
semitransparent foreground color flash (orange, blue or yellow) that appeared during the mid
200ms–650ms of a 1-second presentation of a dynamically changing background face
(neutral to emotional; see Figure 1). These emotional faces occupied the majority of the
screen (approximately 23 visual degrees) and were interleaved with a central crosshair that
was jittered to remain on the screen for 2–3 seconds. Faces from the NimStim stimulus set33
were morphed in 5% increments, from neutral (0% emotion) to 100% emotion for 4
emotions: happy, sad, angry, and fearful. Participants were told to ignore the face as it was
not relevant to their task. Morphed faces were made into 1s movies progressing from 0% to
100% emotion. In control trials, movies comprised a simple shape (dark oval) superimposed
on a light-grey oval, which was subsequently morphed into a larger shape, approximating
the movement shown by the morphed faces. There were 3 blocks for each of the above 4
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types of emotion trial, with 12 stimuli per block (42 second blocks), and 12 control blocks,
with 6 stimuli per block (21 second blocks). Control blocks were half the duration of
emotional blocks in order to minimize the time difference between baseline and conditions
for individual emotion contrasts and lessen the overall time burden on young participants.
Emotional blocks were presented in a pseudorandomized order so that no two blocks of any
condition were presented sequentially. Control blocks were interleaved with emotional
blocks. The task was slightly modified from previously published adult versions for use with
children32,34. A graphical reminder of which color was assigned to each button was visible
on the right side of the screen for the duration of the experiment.
Data Acquisition
At the Pittsburgh site neuroimaging data were collected on a 3.0 Tesla Siemens Trio, at the
Cleveland site neuroimaging data were collected with a 3.0 Tesla Siemens Verio, and at the
Cincinnati site neuroimaging data were collected with a Phillips Achieva 3.0 Tesla X-series
scanner. Structural 3D axial MPRAGE/PAR-REC images were acquired in the same session
(repetition time [TR]/time to echo [TE]=2200/3.29ms, Flip angle 9°, field of view [FOV]:
256×192mm2, Slice thickness: 1mm, Matrix: 256×256, 192 continuous slices). Blood-
oxygen-level-dependent (BOLD) images were then acquired with a gradient echo-planar
imaging (EPI) sequence during approximately 13 minutes (386 successive brain volumes)
covering 39 axial slices (3.2 mm thick, TR/TE=2000/28 ms/ms, FOV=205×205 mm2,
matrix=64×64; Flip angle 90°). Imaging parameters were adjusted identically on all 3
scanners.
Previous studies35,36 indicate the feasibility of combining structural and functional
neuroimaging data from different sites but emphasize the necessity of measuring, and
controlling for intersite differences in scanner signal-to-noise ratio (SNR). To ensure
intrasite reliability among scanners at our 3 study sites and to allow combination of
neuroimaging data across sites, we used the recommended standards published by the
Biomedical Informatics Research Network (BIRN; http://www.nbirn.net) for data
acquisition and information sharing by measuring scanner SNR monthly with BIRN-
recommended phantoms at each site. Additionally, we explored the effects of site and
monthly SNR in our final analyses (see below).
Data Analysis
Data were preprocessed and analyzed using BrainVoyager QX 2.4 (Brain Innovation,
Maastricht, The Netherlands). Preprocessing included slice time correction (cubic spline
interpolation), alignment of slice (cubic spline interpolation to the first nondiscarded scan
time), 3-dimensional motion correction (trilinear interpolation), spatial smoothing (6mm
Gaussian kernel), linear trend removal, and temporal high-pass filtering (fast-Fourier
transform based with a cutoff of 3 cycles/time course). The functional data sets were
coregistered to the Talairach-transformed37 T1-weighted anatomical image series to create a
4-dimensional data representation.
Z-transformed participant movement was entered as a covariate of no interest at the
individual participant level. No participants included in this analysis moved more than 3mm
from their starting head position, neither from movement spikes nor from slow drift, during
the course of data collection. Groups did not significantly differ in mean frame displacement
(F[2,57]=0.49 p=0.61).
Although we were primarily interested in the face processing system, our primary analysis
strategy employed a whole-brain, conservative approach in order to allow for unexpected
findings in other brain regions. A secondary analysis restricted our regions of interest to
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those of the face processing system (Amygdala, FG, STS) using a more liberal threshold.
For both analyses, a multi-participant statistical analysis was performed by multiple linear
regression of the time course of the BOLD response in each voxel across the whole brain.
Regressors were generated to represent the design matrix of the experiment and a general
linear model was computed to fit these regressors to each participant’s z-normalized volume
time courses. Model predictors were defined by convolving an ideal boxcar response with a
gamma-function model of the hemodynamic response38. Boxcar values were equal to 1
during the emotion morph blocks and 0 during shape morph blocks.
First, we computed a 3 (group: BPSD, Non-BPSD, Control) × 4 (condition: happy, sad,
anger, fear) analysis of variance (ANOVA), with shapes as the baseline condition, to
examine the main effects of condition and group and the group × condition interaction
across the whole brain. Activation maps were visualized on a Talairach-transformed
template brain, and displayed at a resolution of 1mm3, and all p-values for all analyses were
subjected to a whole-brain threshold of p<.001 and a 20 3mm3 voxel extent, which is
slightly more conservative than the p<.005 and a 10 voxel extent threshold that has been
proposed in order to balance Type I and Type II error39. Beta values were extracted from
regions displaying the effects of interest and plotted to examine differences between
conditions and groups. Finally, a replication of the analysis described above was conducted
using a region of interest mask of the face processing system (bilateral amygdala, FG, and
STS). Maps for this analysis were subjected to a more liberal threshold of p<.001, with no
voxel extent threshold.
In order to examine the effects of behavioral, demographic, and clinical variables on our
neuroimaging effects, we computed the contribution of these variables to our findings using
SPSS version 20 (IBM Software). Across all groups, relationships were examined between
accuracy and reaction time during color labeling in emotion blocks, as well as demographic
variables, and beta values for extracted activation differences from baseline. In both patient
groups, relationships were examined between comorbid diagnoses and medication usage and
these beta values. A problem for all neuroimaging studies of BPSD is the potential
confounding effect of psychotropic medication, as it is difficult to recruit medication-free
participants into such studies40. Thus, variables representing the taking versus not taking of
each psychotropic medication class (antipsychotic, antidepressant, mood stabilizer, and
stimulant) were examined. All analyses were computed by univariate ANCOVA with
extracted BOLD signal as the dependent variable, group (BPSD, non-BPSD, control) as the
independent variable, and the variable of interest as a covariate.
Results
See Supplement 1 and Figures S1 and S2, available online, for a discussion of data
combination across multiple sites.
Task Performance
Color labeling accuracy and reaction times for emotion blocks were calculated based on
individual participant task performance for each of the 5 conditions (fearful, angry, sad,
happy, and shapes). Overall, color labeling accuracy was 76%, 80%, and 92% for BPSD,
Non-BPSD, and Control, respectively. We computed a repeated measures ANOVA for
accuracy and reaction time with 3 groups (BPSD, Non-BPSD, Control) × 5 conditions
(happy, sad, anger, fear, shapes). For task accuracy, we found a main effect of group (F
[2,56]=4.68, p=.013) and a main effect of condition (F[4,224]=4.35, p=.002), but no group ×
condition interaction. Post-hoc tests of group differences, with a least significant difference
(LSD) correction, revealed decreased accuracy of both the BPSD group (mean difference=.
16, p=.005) and Non-BPSD group (mean difference=.12, p=.03) compared to the control
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group, but the accuracy difference between the two patient groups was not significant.
Pairwise comparisons for each condition, with a LSD correction, revealed decreased
accuracy for the happy condition compared to the sad (mean difference=−.03, p=.01) and
angry (mean difference=−.04, p=.001) conditions and an increased accuracy for the anger
condition compared to the fear condition (mean difference=−.03, p=.01), but not between
any other conditions. Although there was no significant group × condition interaction for
accuracy, we note that scores differed significantly between the BPSD and Control groups
for all conditions (smallest mean difference=.14, all ps≤.02) and did not significantly differ
between patient groups on any conditions (largest mean difference=.06, all ps≥0.28; see
Figure 2).
For reaction time, we found a main effect of condition (F[4,224]=4.892, p=.001), but no
main effect for group or a group × condition interaction. Pairwise comparisons for each
condition, with a LSD correction, revealed increased reaction time for the sad condition
compared to the fearful (mean difference=40.42, p=.001) and shapes (mean
difference=43.56, p<.001) conditions and an increased reaction time for the anger, compared
to the shape conditions (mean difference=25.92, p=.005), but not between any other
conditions. Results did not implicate a speed-accuracy trade off (i.e. significant positive
correlation between speed and accuracy) in the BPSD and Control groups. Overall speed
and accuracy were positively correlated for the Non-BPSD group (r[18]=.55, p=.012).
Neural Activity
The 3 (Group: BPSD, Non-BPSD, Control) × 4 (Condition: happy, sad, angry, fearful)
ANOVA revealed a main effect of group in the left inferior frontal gyrus (F [2,57]≥7.82, p<.
001; see Table 2 for specific cluster size, statistical value, and location information).
Contrasts of the average baseline-corrected neural activity beta values extracted from the
whole of the active cluster, computed using SPSS v20, revealed significant mean differences
between all groups. The Control group had the highest change from baseline (mean=.16,
SE= .03), followed by the Non-BPSD group (mean=.07, SE= .03), followed by the BPSD
group (mean=−.05, SE= .03), whose activity decreased from baseline. There was also a main
effect of condition (F [3,171]≥5.67, p<.001), located in the bilateral superior frontal gyrus.
Here, fear (mean=.10, SE= .04) and happy (mean=.05, SE= .03) were increased from
baseline, though not significantly different from each other, while sad (mean=−.07, SE= .04)
and anger (mean=−.17, SE= .04) decreased from baseline and were each significantly
different from all other conditions.
Finally, a significant group × condition interaction, revealed a single cluster of activation
located in the left FG (F[6,171]≥3.95, p<.001; see Figure 3). This cluster was located in the
vicinity of the fusiform face area based on the work of Kanwisher et al.14 We created a
region of interest based on a 3mm sphere centered at voxel x=−35, y=−63, z=−10, which
was reported by Kanwisher et al. as the center of the left fusiform face area. Beta values for
baseline corrected neural activity levels were then extracted from this region of interest for
the group × condition interaction in order to further explore the contributions of each
individual condition and group to the interaction. The results of a one-way ANOVA for each
condition revealed significant group differences only for the angry condition
(F[2,57]=18.12, p<.001) in this area of the FG. Post-hoc LSD contrasts revealed that the
BPSD group had significantly lower activity levels within the left FG region compared to
the Controls (p<.001) the Non-BPSD group (p<.001; see Figure 3). There were
nonsignificant trends for the one-way ANOVAS for the sad (F[2,57]=2.99, p=.058) and fear
(F[2,57]=2.80, p=.069) conditions.
In order to increase our power to find effects of interest solely within the face processing
system, we computed the above analysis using a bilateral mask of the amygdala, FG, and
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STS with a liberal overall threshold of p<.001, uncorrected. This ANOVA revealed a main
effect of group in the left FG (F [2,57]≥7.82, p<.001; see Table 2 for specific cluster size
and location information). Contrasts of baseline corrected neural activity beta values
extracted from this region revealed significant mean differences between the BPSD and both
other groups but not between the Control and Non-BPSD group. The Non-BPSD group had
the highest change from baseline (mean=.36, SE= .06), followed by the Control group
(mean=.30, SE= .06), followed by the BPSD group (mean=−.01, SE= .06). There was also a
main effect of condition (F [3,171]≥5.67, p<.001), located in the right STS. Here, anger
(mean=.25, SE= .04), fear (mean=.24, SE= .05) and sad (mean=.19, SE= .04) did not
significantly differ from each other but were all 3 higher than happy (mean=.08, SE= .04).
Finally, a significant group × condition interaction, revealed a cluster of activation located in
the left FG (F[6,171]≥3.95, p<.001), overlapping with the interaction effect found at the
whole-brain level. No effect was found in the right or left amygdala.
Relationships Between Demographic Variables, Task Performance, Clinical Variables
To examine the potential effects of demographic variables, task performance, and clinical
variables on the between-group differences found within the FG, the baseline corrected
extracted activation betas, taken from the region of the FG in which the group × condition
interaction was significant (see Figure 2), were used as the dependent variable in a series
univariate analyses of covariance (ANCOVAs). Each ANCOVA model had 2 independent
variables, diagnostic group and the covariate of interest. Here, we used the FG activation for
only the anger condition because it was noted to have the largest difference between groups.
This focused analysis also allowed us to reduce the likelihood of committing a Type 1 error.
The demographic variables, age, sex, SES, and IQ did not have an independent effect on FG
activation to anger (largest F [1, 56]=2.13, p=.15). In each model, the effect of diagnostic
group remained significant even including the covariate in the model (all Fs[2, 56]≥15.29,
all ps<.001). For behavioral variables, task accuracy (F[1, 56]=.68, p=.41) and reaction time
(F[1, 56]=1.96, p=.17) for the anger condition did not have independent effects on FG
activation. The effect of diagnostic group remained significant when controlling for task
accuracy (F[2, 56]=16.85, p<.001) and reaction time (F[2, 56]=18.54, p<.001).
For clinical variables, we examined only the BPSD and Non-BPSD groups. Lifetime history
of comorbid anxiety disorders, ADHD, or disruptive behavior disorders did not have an
independent effect on anger FG activation (all Fs[1, 37]≤1.57, all ps≥.22), and the effect of
diagnostic group remained significant in each model (all Fs[1, 37] ≥31.00, all ps<.001).
Finally, when examining medication effects, use of neither antidepressants, antipsychotics,
mood stabilizers, nor stimulants (taking vs. not taking) had an independent effect on anger
FG activation (all Fs[1, 37]≤1.55, all ps≥.22), and the effect of diagnostic group remained
significant in each case (all Fs[1, 37]≥27.48, all ps<.001).
Data Combination from Multiple Scan Sites
As described earlier, scanner SNR was collected monthly with a BIRN phantom and linked
to each participant’s scan data. Following the same univariate ANCOVA procedure utilized
to examine the effects of demographic, task performance, and clinical variables, we
examined the effect of SNR on average FG activation across emotions. In this model,
diagnostic group, scanner SNR, and scan site were entered as independent variables. Neither
SNR nor scan site had an independent effect on average FG activation (all Fs[1, 56]≤.647,
all ps≥.43), and the effect of diagnostic group on average FG activation remained significant
(all Fs[2, 56]≥4.99, all ps≤.01). For additional analyses relating to multisite data
compilation, see supplemental materials.
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Using a dynamic face processing task, we found evidence for decreased activation of the left
FG in youth with BPSD relative to both a clinical group matched for demographic
characteristics and comorbid psychopathology and a demographically matched healthy
control group. This effect was present in all emotion conditions, but was most apparent for
the anger condition.
Examining all areas of the brain, we found that it was only the FG (“fusiform face area”)
region that showed significant interaction between groups and conditions. This region is
widely noted as a region involved in not only face processing, but key components of social
communication41 such as eye contact42, facial identity recognition43, and mouth
movement44. Although this region has rarely been studied directly in pediatric BPSD,
inferences can be drawn from widely replicated results of hypoactivation and social
impairment in the autism literature45–47. Dalton et al.46, for example, found that visual
fixation upon the eyes of a face was positively correlated with FG activation while
Kleinhans et al.47 found that amygdala to FG functional connectivity was negatively
correlated with social impairments as diagnosed through clinical interview. Future studies
may, therefore, show that similar impairments in social functioning may be linked to FG
hypoactivation in pediatric bipolar disorder. Indeed, in the current study we found FG
hypoactivation in our BPSD group, but not in our group matched for comorbid diagnosis,
whose fusiform activation did not differ from that of a healthy control group. This study
provides preliminary evidence that dysfunction in emotion processing occurs not only in
emotional regions of the brain, which might be expected given the affective challenges of
this mood disorder, but also in basic visual processing of faces. Additionally, we found a
main effect of group in the inferior frontal gyrus, which was highest for the Control group,
possibly indicating increased regulation of affect in response to emotionally evocative
stimuli.
Although participants were asked to perform a task that did not require explicit attention to
emotional faces, we found that FG activation varied according to the type of emotional
distracter in the BPSD group. Specifically, the differences in activation between the BPSD
group and the Non-BPSD group were largest for the angry face condition and smaller,
though still statistically significant, for the sad face condition. Not only is anger an emotion
that is often present in the clinical symptoms of pediatric BPSD2,48, but also previous
studies have pointed to deficits in anger perception in BPSD. In a pediatric BPSD sample
Guyer et al.8 reported the most errors in identifying angry faces compared to other emotions,
and Rich et al.5 reported that neutral faces were perceived as more “hostile” by youth with
BPSD compared to control participants. Neuroimaging studies also have found increased
activation in the amygdala and prefrontal cortex during passive viewing of angry faces in
comparison to control participants49. Our results indicate decreased visual processing of
angry faces in participants with BPSD. This may underlie social impairments often seen in
these youth, who may not effectively detect or may misinterpret the facial cues present in
angry friends or family members.
Many previous studies indicate that there is an overall right greater than left laterality in FG
face-selective activity14,50–52, however, our results were localized to the left hemisphere.
Our findings were mostly driven by the angry face condition. Previous research aimed at
emotional brain asymmetry has indicated lateralized brain activity in the right hemisphere
for withdrawal emotions (e.g., sadness) and lateralized brain activity in the left hemisphere
for approach emotions (e.g., anger)53. For example, in a study of electroencephalography
(EEG) asymmetry, Harmon-Jones54 found that in adults who self-reported high trait anger,
greater relative left frontal cortical activity was observed to anger-invoking pictures, but not
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to other emotional pictures. Although measures of trait anger were not collected in this
sample, the FG asymmetry results observed may be related to differences in emotional
perception of this approach emotion between groups.
Although the findings of this study are promising, some limitations must be noted. Nearly
all clinical participants in this study were medicated and, although covariate analyses
indicate that medication usage did not affect the specific findings of our study, effects of
medication on face perception systems are not well understood. However, previous studies
have argued that medication is more likely to have a normalizing effect in clinical
neuroimaging studies40, so we would not expect medication to introduce spurious
differences. Second, limitations of the current work may be related to the fMRI study
design. In contrast to previous studies of emotional face processing in pediatric bipolar
disorder5,55, our analyses did not find differences in amygdala functioning when viewing
emotional faces. This could be related to the task-irrelevant emotional nature of our design
(requiring no emotional judgment). This could also be related to the lack of task conditions
requiring differential focus on the emotional faces. Indeed, other research that has employed
this technique has found modulation of the amygdala due to varying attentional demands
placed on the stimulus56. Finally, the block design of our study, combined with the differing
accuracy between subject groups on emotion and baseline conditions, can be seen as a
limitation to our interpretation of study findings. The block design of the study did not allow
us to analyze only correct trials, which were significantly fewer in the BPSD and Non-BPSD
groups. As previous studies emphasized46,57, one must investigate the nature of the behavior
involved in the task in order to disambiguate an effect of interest from other neural processes
related to error rate (e.g., conflict monitoring58, executive function59). Additionally, the
possible speed/accuracy trade-off observed in the Non-BPSD group points to possible
behavioral differences among groups that is not easily noted with a block design. Thus, we
encourage our results to be interpreted as an early phase investigation requiring further
replication using event-related task design. Future studies should attempt the analysis of
only correct trials when performance differences arise, which is a confound that is often
unavoidable when investigating young patient groups. We note, however, that in our study,
behavioral differences were only found between the patient and control groups and did not
exist when comparing both patient groups. Thus any possible confound caused by
behavioral performance cannot account for the observed differences between the BPSD and
Non-BPSD children with regard to FG activity to Sad and Angry faces. Further mitigating
the concern that performance confounds may be responsible for any of the results we
observed, the Non-BPSD and healthy control groups did not differ from each other with
regard to FG activity to Anger despite the fact that the Non-BPSD children were
significantly less accurate than the controls during this task condition.
Results of this study suggest that FG deficits in facial processing are specific to pediatric
BPSD rather than a common functional brain abnormality observed in general child
psychopathology. Thus, it is possible that this patient group could benefit from therapeutic
training designed to enhance FG functioning to facilitate positive social interaction. Similar
interventions have been attempted, with mixed success, in studies of Autism Spectrum
Disorders through eye-contact60 and facial expression recognition training61 as well as in
psychosocial treatments for pediatric BPSD50. Before such treatment development work can
commence, however, future studies should consider employing the use of eye-tracking
methodology during fMRI scanning to determine if the observed effect is due to visual
avoidance of emotional faces or simply an effect of inefficiency in the brain’s face
processing circuit in pediatric BPSD. Additionally, studies enrolling young children at risk
for BPSD (e.g., unaffected siblings) could examine longitudinally whether FG
hypoactivation is a biological precursor of this disorder or the result of repeated difficulties
in social interaction throughout the course of development.
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Dynamic Faces Task. Note: Graphic representation of a single happy trial of our emotional
dynamic faces task. Over a one-second duration, the face changed from neutral (0%
emotion) to a happy, sad, angry, or fearful face (100% emotion). Participants were asked to
identify the color flash presented in mid dynamic change.
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Task Accuracy. Note: Task accuracy for each group and condition. The bipolar spectrum
disorder (BPSD) group and the Non-BPSD group did not significantly differ from each other
on any condition. aSignificant statistical difference p<.05.
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Group × Condition Interaction. Note: Results of a whole-brain group × condition interaction,
(F[6,171]≥3.95, p<.001), show decreased activity in the left fusiform gyrus indicated by red
highlights (TAL peak: x=−40, y=−65, z=−15). The bipolar spectrum disorder (BPSD) group
displayed significantly less activity in this region than both the Non-BPSD and Control
groups. aSignificant statistical difference p<.05.
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